Rationale Drift in Medicare Audit Appeals: When the Basis for Denial Changes Mid-Process

Key Takeaways

• Denial rationales can change during appeals: A claim initially denied for documentation deficiencies may later be rejected on entirely different grounds, such as categorical noncoverage, leaving providers unprepared to respond.  
• Medicare rules allow “rationale drift”: Current regulations permit QICs to introduce new issues at reconsideration while simultaneously limiting providers’ ability to submit additional evidence later in the process.  
• Escalation often becomes unavoidable: Because different denial theories require different legal and evidentiary responses, providers may need to pursue costly ALJ hearings simply to fully address the operative basis for denial.  

There is a specific kind of frustration that settles in around the second or third level of a Medicare audit appeal. You have spent months building a clinical record; wound measurements, conservative treatment timelines, product documentation; physician attestations. You addressed every concern the auditor identified, line by line, and submitted the documentation before the deadline. Then the Qualified Independent Contractor (QIC) issues its reconsideration decision, and you realize: the reason your claim denials have changed. 

The documentation issues that drove the initial audit have disappeared from the analysis. The QIC has decided the case on a different theory entirely. The evidence you spent months assembling is not wrong. It is just nonresponsive to the question that ultimately controlled the outcome. 

This pattern has a name. I am calling it rationale drift: the shift in the operative basis for a coverage denial across successive levels of the Medicare appeals process. In my experience managing a 17-month Unity Program Integrity Contractor (UPIC) audit and multilevel appeals process for a wound care practice, I watched it happen across multiple cases. For providers currently navigating the post-payment review environment, particularly those with skin substitute claims, understanding this dynamic is worth the time. 

What It Looks Like 

The sequence typically begins at the UPIC level with a denial grounded in documentation deficiencies. For skin substitute claims, that usually means the auditor “found” that the clinical record failed to show four weeks of failed conservative treatment prior to skin substitute application, adequate wound measurement at baseline, sufficient comorbidity management, or consistent product quantity accounting. The denial is conditional by nature: the implication is that the service might be covered if the documentation were more complete. 

A provider who reads that message the obvious way does what the process appears to invite. Evidence is compiled. Records are supplemented. The appeal is constructed around the specific deficiencies the UPIC identified. 

At reconsideration, the QIC reviews the case. In the cases I examined, the QIC acknowledged that the documentation concerns had been addressed, or more accurately, were always correct from the outset. The clinical records showed wound measurements, conservative treatment history, product quantities used and wasted. The QIC then denied the claims anyway, on grounds the UPIC had never cited: the product at issue, Q-XXXX was deemed experimental and investigational based on its HCPCS code designation. Coverage was categorically excluded, regardless of documentation quality. 

The operative policy framework changed as well. The UPIC had cited LCD L350411, the Local Coverage Determination governing bioengineered skin substitutes for lower extremity wounds. The QIC's written decision stated explicitly that the correct policy was the Medicare Program Integrity Manual, Chapter 3, Section 3.6.2.2,2 which governs coverage determinations in the absence of a Local Coverage Determination. The UPIC cited an existing LCD; the QIC discarded it and applied the framework that applies when no LCD exists. These are not stylistic differences. An LCD-based denial and an absence-of-LCD denial require entirely different evidentiary responses. 

Why the System Allows It 

Rationale drift is not an accident or an administrative error. The regulatory architecture makes it possible. 

Under 42 CFR Section 405.968(b)(5),3 QICs may raise new issues during reconsideration without prior notice to the provider. There is no requirement that a new issue bear any relationship to the original denial rationale. At the same time, evidence front-loading rules under 42 CFR Section 405.966(a)(2)4 require providers to submit all relevant evidence before the QIC issues a decision. Evidence submitted after the fact faces significant barriers to admission at the ALJ level. 

The practical consequence of this combination is that providers are required to front-load all their evidence, but they build that evidence package around the theory they were given. When the QIC decides on a different theory, the provider's carefully assembled record may have no bearing on the controlling analysis. Getting a genuine opportunity to respond to the new theory typically means escalating to an Administrative Law Judge hearing, with the attendant costs, delays, and recoupment exposure. 

CMS has partially addressed this dynamic through a 2015 guidance document, MLN Matters SE1521,5 which instructed MACs and QICs to avoid developing new denial rationales when the original denial reason was cured. The guidance is subregulatory, however, and it does not apply to UPIC fraud-related denials. It has not been codified in the Code of Federal Regulations. In practice, it has not prevented the pattern described here. 

Why It Matters to Your Practice 

The downstream effects of rationale drift are practical and measurable. 

An appeal built to address documentation deficiencies may provide no traction against a categorical noncoverage determination. The clinical record you constructed to show conservative treatment history, wound progression, and medical rationale is not responsive to an argument that a product's HCPCS code designation makes it categorically nonpayable. These are different legal theories requiring different evidence and different arguments. A provider who did not know the second theory was in play had no opportunity to address it. 

The pattern also complicates appeal strategy. Experienced appellants calibrate their cases by assessing the denial's strengths and vulnerabilities. Rationale drift makes that calibration unreliable. A case that looks defensible at the redetermination stage, based on the UPIC's stated rationale, may confront an entirely different framework at reconsideration. Cases that might have resolved at Level 2 end up escalating to Level 3 instead, at significantly greater cost to the provider and greater strain on OMHA's docket. 

For smaller wound care practices without dedicated appeals staff or outside legal counsel, the combination of shifting theories, evidence front-loading rules, and the cost of ALJ escalation can be difficult to absorb. The financial exposure from a UPIC audit already includes not just the specific denied claims but extrapolated overpayment demands that can reach hundreds of thousands of dollars. Adding procedural complexity to that environment amplifies the pressure considerably. 

Naming the Problem 

The reason I am writing about this is partly because I have not seen it discussed in wound care practice management literature, despite the fact that it is a structural feature of how the appeals system operates rather than an isolated anomaly. Providers in the middle of a complex appeal are typically focused on the immediate demands of documentation and deadlines. Recognizing a systemic pattern requires a kind of analytical distance that is hard to maintain when recoupment timelines are running. 

Rationale drift does not describe a regulatory violation. The QIC is operating within its stated authority. The problem is the combination: broad new-issue authority at the reconsideration level, paired with evidentiary restrictions that assume the dispute is stable across levels. When those two features interact in a case, the provider faces a moving target without a procedural mechanism to catch up. That is not a fair and just due process. 

Recognizing this pattern when it appears in your cases will not resolve the underlying denial. But it may clarify what actually happened, frame the argument for the ALJ more precisely, and explain why some appeals require escalation before the relevant issues are fully aired. For practices managing active audits, that clarity has real value. 

Lance McNeill, MBA, MPAff, is the founder of Arclight Action, a Medicare audit reform and policy consulting practice. He spent 17 months navigating a UPIC post-payment audit and multi-level appeals process as the operations manager of Victory Wound Care, a mobile wound care practice in Austin, Texas. He holds a Master of Public Affairs from the LBJ School of Public Affairs at The University of Texas at Austin and an MBA from Texas State University. 

The author discloses that Anthropic's Claude, OpenAI's ChatGPT and XAi's Grok were used for fact checking, creating outlines, editing for flow and helping tailor the information to this specific audience. However, the concepts, tone and writing are all the author's own. 

References 

1. Centers for Medicare & Medicaid Services. LCD - Application of Bioengineered Skin Substitutes to Lower Extremity Chronic Non-Healing Wounds (L35041). Medicare Coverage Database. Accessed May 15, 2026. https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?LCDId=35041  

2. Centers for Medicare & Medicaid Services. Medicare Program Integrity Manual, Chapter 3: Verifying Potential Errors and Taking Corrective Actions. CMS Publication 100-08. Revised August 27, 2021. Accessed May 15, 2026. https://www.cms.gov/regulations-and-guidance/guidance/manuals/downloads/pim83c03.pdf  

3. Electronic Code of Federal Regulations. 42 CFR §405.968 - Reconsideration process. Accessed May 15, 2026. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-405/subpart-I/subject-group-ECFR533a2e506b78025/section-405.968  

4. Electronic Code of Federal Regulations. 42 CFR §405.966 - Submission of evidence. Accessed May 15, 2026. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-405/subpart-I/subject-group-ECFR533a2e506b78025/section-405.966  

5. Centers for Medicare & Medicaid Services. MLN Matters SE1521: Changes in the Amount in Controversy Thresholds and Other Requirements for Medicare Appeals. Published August 2015. Accessed May 15, 2026. https://s3.amazonaws.com/aafh/downloads/881/MLN_SE1521_Post_Pay_Review_080115.pdf